Nuclear Medicine and Biology
Volume 35, Issue 4 , Pages 425-432, May 2008

Method for stabilizing non carrier added 2-[18F]fluoromethyl-l-phenylalanine, a new tumour tracer, during radiosynthesis and radiopharmaceutical formulation

Radiopharmaceutical Chemistry, BEFY, Vrije Universiteit Brussel, 1090 Brussels, Belgium

Received 16 July 2007; received in revised form 21 December 2007; accepted 11 January 2008. published online 07 April 2008.

Abstract 

Introduction

Non carrier added (NCA) 2-[18F]fluoromethyl-l-phenylalanine is currently used in a Phase I study. Improvement of the stability of the fluorobenzyl analogue, very sensitive to defluorination and hydrolysis, during the synthetic route and in the radiopharmaceutical formulation was devised.

Methods

The protected brominated precursor was synthesised in three steps. The labelling with [18F] occurred in acetonitrile using K2CO3/K2.2.2 (120°C, 5 min). NCA 3-(2-[18F]Fluoromethyl-phenyl)-2-tert-butoxycarbonylamino-propionic acid tert-butyl ester recovered from HPLC was submitted to deprotection in TFA/CH2Cl2 in the presence of CaCl2. After evaporation and adsorption on a mini C18 column, the tracer was recovered in 4 ml of H2O. Appropriate amounts of CaCl2 and NaCl solutions were added for isotonic formulation, and this solution was sterilised by a 0.2-μm Cathivex filter. Shelf-life stability in the presence of Ca2+ and Mg2+ ions was studied. Stereoisomeric purity was checked by chiral HPLC.

Results

The labelling showed a reproducible labelling yield of at least 90%. The followed strategy and the presence of Ca2+ ions during deprotection, minimizing the loss of [18F] from the labile fluorobenzyl group, allowed to obtain a decay-corrected yield of 75%. No racemisation was observed. The radiopharmaceutical formulation containing 0.04 M CaCl2 allows a shelf-life of about 6 h without significant radiodefluorination.

Conclusion

The described synthetic route yields 40% of radiochemical pure NCA 2-[18F]fluoromethyl-l-phenylalanine within 105 min. A solution was found to reduce considerably the radiodefluorination. Addition of CaCl2 prior to deprotection limits the loss of radiofluoride to less than 10%. The calcium ions present in the final radiopharmaceutical formulation (0.04 M) assure a shelf-life of at least 6 h.

Keywords: 2-[18F]Fluoromethyl-l-phenylalanine, Nucleophilic 18F-fluorination, Ca2+ ions, Stability, Shelf-life

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The first author is currently in training as a PhD student.

PII: S0969-8051(08)00036-X

doi:10.1016/j.nucmedbio.2008.01.003

Nuclear Medicine and Biology
Volume 35, Issue 4 , Pages 425-432, May 2008